Category: Alabama Opioid Prescribing, All Specialties, Pain Management Category: Alabama Opioid Prescribing, All Specialties, Pain Management (show less)

This on-demand activity can contribute to the 2 credits of continuing education every two years required of Alabama Controlled Substances Certificate holders. 

Description:
Opioid use disorder (OUD) impacts over 26 million people globally. Buprenorphine has been a key treatment for OUD internationally since the 1990s and has been available in the United States for over a decade. With its unique properties, buprenorphine offers a practical solution for both adults and adolescents managing opioid use disorder and/or acute or chronic pain. This course will explore treatment strategies and effective management of opioid use disorder in patients receiving buprenorphine.

CME Objectives:
After completing this activity, learners will be able to:

• Describe best practices when prescribing buprenorphine, including induction strategies and dosing regimens. 
• Recognize the potential complications when switching patients from fentanyl or methadone to buprenorphine.

 
Disclosure:
The speaker, planners and staff who control content have no relevant financial relationships to disclose.  
 
Estimated Completion Time:
60 Minutes
 
Instructions for Earning Credit:  Learner must review all of the content included in the online video course, pass the online post-test with a score of at least 80%, and complete the course evaluation electronically. Note: Post-test is automatically locked after four unsuccessful attempts.

Recorded:11/23/2024
Released: 2/25/2025
Expires: 02/25/2028

Refund Policy: Registration is not refundable.